How much funding has OmicsChart raised?

OmicsChart has raised $20K in total funding, most recently a Seed round.

Who are OmicsChart's investors?

OmicsChart's investors include Techstars, PharmStars, Debiopharm Innovation.

When was OmicsChart founded?

OmicsChart was founded in 2023.

Where is OmicsChart headquartered?

OmicsChart is headquartered in Martinsried, Germany.

What industry is OmicsChart in?

OmicsChart operates in Artificial Intelligence, Data & Analytics, Healthcare, Oncology.

OmicsChart

AI in biopharma only delivers value when data, analysis, and decisions are tightly connected

Martinsried, Germany · Founded 2023 · $20K raised

Artificial Intelligence

Data & Analytics

Healthcare

Oncology

Headquarters: Martinsried
Employees: 1–10
Founded: 2023
Business Model: B2B

Website: omicschart.com
Total Funding: $20K
Last Round: $20K SeedJun 2023
Rounds: 1

About

OmicsChart (now rebranded as Vedaly) is a patient-centric cancer data and analytics platform for translational cancer biologists and biopharma R&D teams. The platform enables translational and R&D teams to architect scalable data foundations, integrate complex biological and clinical data, and operationalize AI so it directly informs scientific and strategic decisions. OmicsChart joined the Milner Therapeutics Institute network at Cambridge University in 2024 and rebranded to Vedaly in November 2025 to reflect its expanded scope of services.

Summary

OmicsChart is an Artificial Intelligence company based in Martinsried, Germany, founded in 2023. It has raised $20K in total across 1 round, most recently a $20K Seed round in Jun 2023. Investors include Techstars, PharmStars and Debiopharm Innovation.